|
LUC7L2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.480840E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.886000E-01 |
| Normal-vs-Stage2 |
8.257200E-01 |
| Normal-vs-Stage3 |
2.052100E-02 |
| Normal-vs-Stage4 |
1.884160E-03 |
| Stage1-vs-Stage2 |
8.712200E-01 |
| Stage1-vs-Stage3 |
1.204390E-02 |
| Stage1-vs-Stage4 |
5.612800E-04 |
| Stage2-vs-Stage3 |
1.397160E-01 |
| Stage2-vs-Stage4 |
5.012300E-02 |
| Stage3-vs-Stage4 |
4.143000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.078300E-02 |
| Normal-vs-AfricanAmerican |
3.685600E-01 |
| Normal-vs-Asian |
1.488840E-01 |
| Caucasian-vs-AfricanAmerican |
8.037400E-01 |
| Caucasian-vs-Asian |
9.350300E-02 |
| AfricanAmerican-vs-Asian |
1.087810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.300200E-02 |
| Normal-vs-Female |
7.739000E-01 |
| Male-vs-Female |
6.508100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.708000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.961800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.526300E-02 |
| Normal-vs-Age(81-100Yrs) |
6.873600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.090600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.365800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.143000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.265410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.569500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.278600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.456000E-02 |
| Normal-vs-Grade 2 |
4.823600E-01 |
| Normal-vs-Grade 3 |
9.376500E-03 |
| Normal-vs-Grade 4 |
1.226230E-04 |
| Grade 1-vs-Grade 2 |
1.120370E-01 |
| Grade 1-vs-Grade 3 |
9.609000E-04 |
| Grade 1-vs-Grade 4 |
5.96079999999333E-05 |
| Grade 2-vs-Grade 3 |
1.604490E-04 |
| Grade 2-vs-Grade 4 |
1.12740000002276E-06 |
| Grade 3-vs-Grade 4 |
4.035900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.226800E-01 |
| Normal-vs-ccB subtype |
2.821800E-03 |
| ccA subtype-vs-ccB subtype |
4.29229999987513E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.145200E-01 |
| Normal-vs-N1 |
4.619700E-02 |
| N0-vs-N1 |
2.240800E-01 |
|
|
